BACKGROUND: Reflux esophagitis (RE) is a chronic inflammatory condition resulting from the reflux of gastric contents. Mucin 6 (MUC6), a member of the mucin family, has been found to have dysregulated expression in various esophageal diseases. However, the specific role of MUC6 in RE remains largely unclear. METHODS: MUC6 levels were detected in esophageal tissues between RE patients and non-RE patients using RT-qPCR and western blot assays. Additionally, to stimulate RE in vitro, human esophageal epithelial cells (HEEC) were exposed to hydrochloric acid (HCl) with a pH of 3.0. To mimic RE in vivo, hemipyloric ligation combined with cardiomyotomy was performed. RESULTS: MUC6 levels were significantly higher in esophageal tissues of RE patients compared to non-RE patients. Meanwhile, elevated MUC6 levels were also observed in HCl-stimulated HEEC cells and in esophageal tissues of rats with RE. Downregulation of MUC6 notably attenuated the inflammatory response both in vitro and in vivo, as evidenced by a reduced production of IL-6. Additionally, silencing MUC6 remarkably improved esophageal epithelial barrier dysfunction in vitro and in vivo through upregulating tight junction protein ZO-1. Meanwhile, MUC6 knockdown resulted in increased levels of E-cadherin, and decreased levels of N-cadherin, vimentin, transforming growth factor-beta 1 (TGF-β1) and Smad3 in RE models both in vitro and in vivo. CONCLUSION: Collectively, MUC6 knockdown could improve esophageal epithelial barrier dysfunction and inhibit epithelial-mesenchymal transition in HCl-stimulated HEEC cells and in esophageal tissues of RE rats, potentially via modulation of the TGF-β1/Smad3 signaling pathway. These data suggested that MUC6 may be a promising target for diagnosis and treatment of RE. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12876-025-04336-6.
Downregulation of MUC6 improves esophageal epithelial barrier dysfunction and inhibits epithelial-mesenchymal transition in reflux esophagitis.
MUC6 的下调可改善食管上皮屏障功能障碍,并抑制反流性食管炎中的上皮-间质转化。
阅读:4
作者:
| 期刊: | BMC Gastroenterology | 影响因子: | 2.600 |
| 时间: | 2026 | 起止号: | 2026 Jan 22; 26(1):53 |
| doi: | 10.1186/s12876-025-04336-6 | 研究方向: | 炎症/感染 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
